Skip to main content

Product News, Studies & Articles

Oncology, Hematology & CAR-T

Product News, Studies & Articles

Novel Therapies for Metastatic Triple-Negative Breast Cancer: ...

måndag, 31 maj 2021 12:30
Triple-negative breast cancer (TNBC) is a biologically heterogeneous disease that is often associated with worse...

ImmunityBio (IBRX) Announces FDA Authorizes its Study of Ankti...

tisdag, 15 juni 2021 12:30
Open-label Phase 1b/2 study will evaluate the safety and preliminary efficacy of Anktiva (N-803) and PD-L1 t-haN...

Moving Towards Targeted Therapies for Triple-Negative Breast C...

måndag, 07 juni 2021 12:30
In this review, we discuss targets of interest in triple-negative breast cancer (TNBC), approved targeted agents...